President and CEO
United States of America
Mike has over 25 years of experience in pharmaceutical and biotech industry. He has led the company since March 2015 as President and CEO at the time JCL Bioassay USA, Inc. joined CMIC Group as a wholly owned subsidiary. Mike also serves as Corporate Officer, Presidents Office, CMIC HOLDINGS Co., Ltd. reporting to its CEO and Board of Directors advising on CMIC’s biotech and large molecule investments.Mike previously held a number of governance, operational and leadership roles at the healthcare and life sciences divisions of General Electric and Japan Tobacco, Japan and United States. He has always been active in liaison roles among science/technology and business/commercial as well as driving cross-functional/cross-cultural teams to deliver innovation.Mike earned bachelor and master degrees in agricultural biosciences from University of Tokyo. He also completed General Electric’s company internal training at its Crotonville, New York main campus.